An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...
1don MSN
Legal questions swirl around FDA's new expedited drug program, including who should sign off
The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is starting the new year with its first ...
Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...
2don MSN
Exclusive-US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track program ...
Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results